ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001765253

Versant Vantage I, L.P.

CIK 0001765253 Name as filed on the most recent filing

Filed as Versant Vantage I, L.P. (29)

104 transaction lines · from 29 filings · filed 2019-10-07 to 2025-09-23 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2020-11-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 12,433 disposed 34.14 424,509.87 Form 4, filing 0000899243-20-030855
2020-11-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 11,388 disposed 33.48 381,245.19 Form 4, filing 0000899243-20-030855
2020-11-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,642 disposed 34.14 56,064.12 Form 4, filing 0000899243-20-030855
2020-11-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,503 disposed 33.48 50,317.13 Form 4, filing 0000899243-20-030855
2020-11-09 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 5,565 disposed 33.06 183,954.41 Form 4, filing 0000899243-20-030745
2020-11-09 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 735 disposed 33.06 24,295.87 Form 4, filing 0000899243-20-030745
2020-11-06 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,738 disposed 33.13 90,705.83 Form 4, filing 0000899243-20-030745
2020-11-06 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 362 disposed 33.13 11,992.52 Form 4, filing 0000899243-20-030745
2020-11-05 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 7,816 disposed 33.15 259,079.30 Form 4, filing 0000899243-20-030580
2020-11-05 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,032 disposed 33.15 34,208.01 Form 4, filing 0000899243-20-030580
2020-11-04 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,208 disposed 33.14 73,163.63 Form 4, filing 0000899243-20-030580
2020-11-04 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 292 disposed 33.14 9,675.62 Form 4, filing 0000899243-20-030580
2020-10-27 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 707 disposed 33.03 23,353.98 Form 4, filing 0000899243-20-029546
2020-10-27 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 93 disposed 33.03 3,072.02 Form 4, filing 0000899243-20-029546
2020-10-26 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 7,158 disposed 33.30 238,394.33 Form 4, filing 0000899243-20-029546
2020-10-26 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 945 disposed 33.30 31,472.85 Form 4, filing 0000899243-20-029546
2020-10-20 Aligos Therapeutics, Inc.
ALGS 		P, Open-market purchase 200,000 acquired 15.00 3,000,000.00 Form 4, filing 0001567619-20-018008
2020-10-19 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 3,739 disposed 33.43 124,998.14 Form 4, filing 0000899243-20-028811
2020-10-19 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 494 disposed 33.43 16,514.86 Form 4, filing 0000899243-20-028811
2020-10-16 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 7,697 disposed 33.57 258,409.84 Form 4, filing 0000899243-20-028811
2020-10-16 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,016 disposed 33.57 34,109.96 Form 4, filing 0000899243-20-028811
2020-10-15 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,473 disposed 33.03 81,693.82 Form 4, filing 0000899243-20-028811
2020-10-15 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 327 disposed 33.03 10,802.22 Form 4, filing 0000899243-20-028811
2020-10-14 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 4,859 disposed 33.09 160,787.23 Form 4, filing 0000899243-20-028366
2020-10-14 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 642 disposed 33.09 21,244.17 Form 4, filing 0000899243-20-028366
2020-10-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 10,370 disposed 33.39 346,270.89 Form 4, filing 0000899243-20-028366
2020-10-13 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,369 disposed 33.39 45,713.10 Form 4, filing 0000899243-20-028366
2020-10-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 353 disposed 33.11 11,686.95 Form 4, filing 0000899243-20-028070
2020-10-12 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 47 disposed 33.11 1,556.05 Form 4, filing 0000899243-20-028070
2020-10-09 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 3,357 disposed 33.67 113,018.44 Form 4, filing 0000899243-20-028070
2020-10-09 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 443 disposed 33.67 14,914.26 Form 4, filing 0000899243-20-028070
2020-10-08 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 8,502 disposed 33.68 286,352.46 Form 4, filing 0000899243-20-028070
2020-10-08 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 7,774 disposed 33.25 258,461.40 Form 4, filing 0000899243-20-028070
2020-10-08 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,122 disposed 33.68 37,789.63 Form 4, filing 0000899243-20-028070
2020-10-08 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 1,027 disposed 33.25 34,144.57 Form 4, filing 0000899243-20-028070
2020-10-07 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 24,590 disposed 33.56 825,154.34 Form 4, filing 0000899243-20-027852
2020-10-07 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 3,246 disposed 33.56 108,924.40 Form 4, filing 0000899243-20-027852
2020-10-06 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 15,980 disposed 33.26 531,477.22 Form 4, filing 0000899243-20-027852
2020-10-06 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 2,110 disposed 33.26 70,176.28 Form 4, filing 0000899243-20-027852
2020-08-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 6,692 disposed 33.08 221,380.06 Form 4, filing 0000899243-20-022188
2020-08-11 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 883 disposed 33.08 29,210.79 Form 4, filing 0000899243-20-022188
2020-08-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 5,492 disposed 33.04 181,445.79 Form 4, filing 0000899243-20-022188
2020-08-10 Black Diamond Therapeutics, Inc.
BDTX 		S, Open-market sale 725 disposed 33.04 23,952.70 Form 4, filing 0000899243-20-022188
2020-06-23 Repare Therapeutics Inc.
RPTX 		P, Open-market purchase 150,000 acquired 20.00 3,000,000.00 Form 4, filing 0001209191-20-039019
2020-06-23 Repare Therapeutics Inc.
RPTX 		P, Open-market purchase 100,000 acquired 20.00 2,000,000.00 Form 4, filing 0001209191-20-039019
2020-03-03 Passage BIO, Inc.
PASG 		P, Open-market purchase 225,000 acquired 18.00 4,050,000.00 Form 4, filing 0001209191-20-015670
2020-02-03 Black Diamond Therapeutics, Inc.
BDTX 		P, Open-market purchase 396,082 acquired 19.00 7,525,558.00 Form 4, filing 0000899243-20-003371
2020-02-03 Black Diamond Therapeutics, Inc.
BDTX 		P, Open-market purchase 396,081 acquired 19.00 7,525,539.00 Form 4, filing 0000899243-20-003371
2020-02-03 Black Diamond Therapeutics, Inc.
BDTX 		P, Open-market purchase 79,013 acquired 19.00 1,501,247.00 Form 4, filing 0000899243-20-003371
2020-02-03 Black Diamond Therapeutics, Inc.
BDTX 		P, Open-market purchase 23,560 acquired 19.00 447,640.00 Form 4, filing 0000899243-20-003371

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Versant Vantage I, L.P., insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001765253

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.